Clinical Trial Update: Efficacy of Targeted Drugs Combined With Chemotherapy in the Treatment of T-ALL [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating targeted drugs combined with chemotherapy for T-cell acute lymphoblastic leukemia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• T-cell Acute Lymphoblastic Leukemia

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Acute Lymphoblastic Leukemia | Phase 3 | Status: RECRUITING